Scope: Phytophenols present in cereals are metabolised to compounds that could be partly responsible for the reduced risk of chronic diseases and all-cause mortality associated with fibrerich diets. The bioavailability, form and in vivo concentrations of these metabolites require to be established. Materials and methods: Eight healthy volunteers consumed a test meal containing a recommended dose (40 g) and high dose (120 g) of ready-to-eat wheat bran cereal and the systemic and colonic metabolites determined quantitatively by LC-MS. Conclusion: Analysis of the systemic metabolomes demonstrated that a wide range of phytophenols were absorbed/excreted (43 metabolites) within 5 h of consumption. These included 16 of the 21 major parent compounds identified in the intervention product and several of these were also found to be significantly increased in the colon. Not all of the metabolites were increased with the higher dose, suggesting some limitation in absorption due to intrinsic factors and/or the food matrix. Many compounds identified (e.g. ferulic acid and major metabolites) exhibit anti-inflammatory activity and impact on redox pathways. The combination of postprandial absorption and delivery to the colon, as well as hepatic recycling of the metabolites at these concentrations, is likely to be beneficial to both systemic and gut health.
Introduction
Diets containing whole grain (WG) cereals can be protective against several cancers and metabolic disorders such as type 2 diabetes mellitus, cardiovascular disease and coronary artery disease. This is clearly demonstrated through both epi-demiological evidence and intervention studies [1] [2] [3] [4] [5] [6] [7] [8] . There are many factors, which may contribute to disease development, but subclinical inflammation is recognised as an important aspect [6] . WG cereals have been shown to impact on inflammatory markers, but there is a gap in the knowledge as to the bioactive dietary factors responsible [7, 8] . The biological effects are mainly attributed to the fibre and the non-nutrient phytochemical content of WG cereals. Phytochemicals, and in particular phytophenols, are of particular interest, as these are located in the outer layer of the grain and in the germ fraction; the bran fraction playing the more important role due to the germ being released during cereal (2 of 15) 1600202 processing [9, 10] . The biological activity of the phytophenols depends on bioaccessibility from the food matrix, as well as bioavailability, metabolism and catabolism in vivo [11] . It is important that the biological effects should not just be attributed to the parent compounds present in foods, but also to the various metabolites produced in the body [12] . The small intestine plays a major role in absorption and metabolism of dietary phytophenols. However, many of these compounds, especially those attached to other cellular components such as fibre, are not absorbed early in the gastrointestinal tract and are delivered to the colon relatively intact, where they are extensively metabolised by the gut microbiota prior to being absorbed and/or excreted [13] . Additionally, the microbial species can be influenced by dietary intake with consequences for impacting on human health [14] . When absorbed from the colon, microbial metabolites can be transported via the hepatic portal system, where they can generate numerous circulating metabolites [15] . In order to comment on potential health benefits of dietary constituents, it is important to determine the bioavailability and structure of these potentially bioactive metabolites [16] . The aim of this study is to identify and quantify the main phytophenol metabolites delivered to both the colon and to the systemic circulation after consumption of ready-to-eat wheat bran cereal and additionally to determine whether their absorption is concentration dependant.
Materials and methods

Study design
Volunteers recruited undertook a general health screen to check they met the study criteria and were asked to complete food frequency and physical activity questionnaires. The volunteers recruited were asked to follow their normal diet until 3 days before the intervention at which time they consumed a low phytochemical diet and completed food diaries. Volunteers were fasted for 12 h prior to commencing the intervention and were not permitted to drink or eat anything within the first 5 h following consumption. For the remaining intervention period (24 h ), volunteers could consume the low phytochemical diet. Each volunteer consumed wheat bran rich cereal at a recommended serving (40 g) along with semiskimmed milk (125 mL) and the high-fibre serving (120 g) with semi-skimmed milk (375 mL). These servings provided approximately 10.8 and 32.4 g of wheat bran fibre (data provided by the manufacturer). There was a washout period of at least 2 weeks between interventions. Baseline faecal, blood and urine sample were collected prior to beginning the intervention, and blood and urine samples were collected at 1, 3 and 5 h during the intervention period (Fig. 1A) . Additionally, urine was collected throughout the 24-h study period and a fasted blood sample at 24 h (data not shown). The first faecal sample after completion of the study was also collected. Containers, cool bags and ice packs, along with clear guidance for storing the urine and faecal samples were provided. The studies followed all the principles of Declaration of Helsinki and good clinical practice, and all procedures involving human subjects were reviewed and approved by the Human Studies Management Committee of the Rowett Institute of Nutrition and Health, University of Aberdeen, UK, and the Rowett Institute Ethics Panel. The study was carried out from February 2012 until June 2012.
Volunteer recruitment
Eight healthy volunteers (seven females and one male, age 38.62 ± 10.8 (23-54) years, BMI 23.39 ± 2.63 (19.94-26 .85) kg/m 2 ) were recruited for the study. Local ethical committee approval was received and written informed consent was obtained from each subject. Selection took place following a general medical screening made by a qualified medical doctor and confirmation of adherence to inclusion/exclusion criteria. Inclusion criteria: healthy, nonsmokers, between 18 and 55 years old, BMI between 18 and 30 kg/m 2 . Exclusion criteria: Taking any prescribed medicines, analgesics, antipyretic, anti-inflammatory compounds or nutritional supplements. Volunteers who had taken antibiotics or who had given a large blood donation in last 3 months prior to taking part in the study were also excluded. Volunteers were asked to complete the validated Scottish Collaborative Group Food Frequency questionnaire to assess habitual fibre intake. Volunteers were provided with information on which foods to avoid for 3 days prior to and during the intervention and asked to complete a 4-day food diary during this period to check for compliance. All eight volunteers took part in the acute intervention to assess bioavailability (Fig. 1) . Data are given for all phytochemicals present in the intervention product at concentrations of greater than 1 mg/kg and is presented as mean ± standard deviation and is expressed as mg/kg dry weight.
Intervention product
The intervention product used for the study was commercially available (Kellogg's All-Bran original cereal). The intervention product was analysed as described previously [17] . In brief,
samples (approximately 0.1 g dry weight; n = 3) were suspended in HCl (0.2 mol/dm 3 ; 3 cm 3 ) and the free phenolic acids extracted into ethyl acetate (EtOAc; 5 cm 3 ). The layers were separated by centrifugation (5 min; 1800 × g; 4 ЊC), the extraction repeated three times and the EtOAc extracts combined. To liberate both the acid-and alkali-labile esterified phenolic acids, the aqueous fraction was sequentially hydrolysed by both alkali (NaOH; 1 mol/dm 3 ; room temperature) and acid (HCl; 6 mol/dm 3 ; 95 ЊC), extracting into EtOAc as described above. All extracts were left to stand over sodium sulphate (anhydrous) for 1 h, filtered and the combined organic layers evaporated to dryness under reduced pressure at a temperature not exceeding 40 ЊC. The extracts were then re-dissolved in methanol (0.5 cm 3 ) and prepared for LC-MS analysis as described below.
General reagents
The methanol used was of LC-MS grade and obtained from Fluka, hydrochloric acid was of analytical grade and obtained from Fisher, sulphatase (S9626) and glucuronidase (G7017) were purchased from Sigma. The internal standards for MS were 13C-benzoic acid form ISOTEC (TJ2365; IS1), and 2-amino-3,4,7,8-tetramethylimidazo [4,5-f] quinoxaline from TRC (A630000; IS2).
Human sample processing
Blood was collected directly into heparinised tubes at the 0, 1, 3, 5 and 24 h time points. The samples were centrifuged (1500 × g, 15 min; 4 ЊC) within 45 min to separate (4 of 15) 1600202 the plasma. Urine samples were measured by weight and volume at the same time points up to 5 h, and then the total 24-h sample collected. The harvested plasma and the urine were aliquoted and stored at -80 ЊC. The faecal samples were weighed, mixed and immediately frozen at -80 ЊC. Faecal samples were thawed, mixed once again, weighed and the faecal waters (FWs) separated using a high-speed centrifuge (50 000 × g; 2 h; 10 ЊC). The FW (supernatant) was carefully removed, aliquoted into Eppendorf tubes and immediately stored at -80 ЊC for LC-MS analyses. Surplus of all the human samples was retained for use in future-related research under signed consent by volunteers before participating in the study.
Human samples analysis
Conjugated systemic metabolites
Urine and plasma samples were thawed to 4 ЊC and 150 L was transferred to an Eppendorf tube, and sulphatase (H-1 Helix pomatia; 0.5 units in citrate phosphate buffer 0.3 mol/dm 3 ; pH 6; 120 L) and glucuronidase (HP-2 Helix pomatia 100 390 units/mL; 30 L) were added. Samples were incubated for 18 h at 37 ЊC; IS1 (60 L), IS2 (60 L) and acidified (0.4 mol/dm 3 HCl) methanol (180 L) were added; and vortexed and centrifuged (12 500 × g; 5 min; 4 ЊC).
Faecal metabolites
FWs samples were thawed to 4 ЊC and 80 L transferred to an Eppendorf tube. Internal IS1 (80 L), IS2 (80 L) and methanol (160 L) were added, and vortexed and centrifuged (12 500 × g; 5 min; 4 ЊC).
LC-MS analysis
LC separation of the metabolites produced was performed on an Agilent 1100 HPLC system (Agilent Technologies, Wokingham, UK) using a Zorbax Eclipse 5 m, 150 mm × 4 mm column (Agilent Technologies). Three different gradients (1-3) were used to separate the different categories of metabolites, and the mobile phase solvents in each case were water containing 0.1% acetic acid and acetonitrile containing 0.1% acetic acid. In all cases, the flow rate was 300 L/min with an injection volume of 5 L. The LC eluent was directed into, without splitting, an ABI 3200 triple quadrupole mass spectrometer (Applied Biosystems, Warrington, UK) fitted with a Turbo Ion Spray TM source. For LC methods 1 and 2, the mass spectrometer was run in negative ion mode with the following source settings: ion spray voltage -4500 V, source temperature 400 ЊC, gases 1 and 2 set at 15 and 40, respectively, and the curtain gas set to 10. For LC method 3, the mass spectrometer was run in positive ion mode with the following source settings: ion spray voltage 5500 V, source temperature 400 ЊC, gases 1 and 2 set at 14 and 40, (6 of 15) 1600202 Data are given as mean ± standard deviation in ng/cm respectively, and the curtain gas set at 10. All the metabolites were quantified using multiple reaction monitoring. Standard solutions (10 ng/L) for all analytes were prepared and pumped directly via a syringe pump. The ion transitions for each of the analytes were determined based upon their molecular ion and a strong fragment ion. For several categories of compounds, it was inevitable that their molecular ion and fragment ion would be the same, but this was overcome by their differing elution times. Their voltage parameters, declustering potential, collision energy and cell entrance/exit potentials, were optimised individually for each analyte.
Statistical analysis
All data are expressed as mean ± standard deviation. Metabolic data sets were analysed by multivariate principal component analysis (PCA) (SIMPCA-P+). The effect of treatment over time (plasma and urine metabolites) was assessed by two-sided post-hoc t-tests and the faecal metabolites by logscale Anova with post-hoc least significant different tests for each of the interventions using the volunteers as their own controls. Genstat version 13 (VSN International) was used for these calculations and there were no indications of departures from equal variances.
Results
Principal component analysis (PCA) showed that the overall metabolite profiles in urine differed at 0, 1, 3 and 5 h following consumption of high ( Fig. 2A) and low (Fig. 2B) amounts of wheat bran. The urinary metabolome within the first 5 h of consumption of the intervention product gives the best indication of the metabolites that have been absorbed early in the gastrointestinal tract. As concentrations are generally higher in the urine compared to plasma, changes in metabolites present at lower amounts can be determined. The data showed some inter-individual variation, but despite this, quantitative analysis of the individual metabolites present in urine showed that around 43 metabolites were significantly modulated by the intervention. Of the 21 major parent metabolites identified to be present in wheat bran (Table 1) , 16 were significantly increased in urine following consumption (Table 2 -4) . In general, most metabolites were excreted at higher concentrations during the acute intervention with a high dose of wheat bran. For some metabolites, the increase was less than threefold, suggesting that the amount of metabolites absorbed early in the gastrointestinal tract may be limited by intrinsic factors, such as gut transporters, enzymes and food matrix effects [18] . Absorption is also likely to be influenced by other components in the plant matrix or in the milk. However, the ratio of cereal to milk was kept constant to standardise these effects. As observed previously, the recovery of the hydroxylated benzoic acids in the urine was substantially higher than the recovery of hydroxycinnamic acids, suggesting that these compounds are more easily or competitively absorbed early in the gastrointestinal tract [19] . The overall profiles of the metabolites in plasma for both the high and low wheat bran interventions (Fig. 3A and B) were not as clearly discriminated when compared to the PCA of the urinary metabolites ( Fig. 2A and B) . This is likely to reflect the lower concentration of metabolites present in plasma, as well as high variability due to dynamic exchange. However, the major metabolites found in wheat bran; ferulic acid and ferulic 5-5-linked dimer, were significantly (p < 0.05) increased in the plasma, as were 2,6-dihydroxybenzoic acid, 3,5-dihydroxycinnamic acid, syringic acid and phenylacetic acid (Tables 5-7) . It should be noted that certain metabolites, particularly, phenylacetic acid, 4-hydroxyphenylacetic acid, phenylpyruvic acid, 4-hydroxyphenylpyruvic acid, phenyllactic acid, 4-hydroxyphenyllactic acid, indole-3-acetic acid, indole-3-pyruvic acid, indole-3-lactic acid and p-cresol, were present in high amounts. These were consistent throughout and not significantly affected by consumption of the intervention product. These have been shown previously to be gut metabolites of the aromatic amino acids and could be a consequence of the low phytochemical diet on which the volunteers were placed prior to the intervention [20] .
PCA shows discrimination between the faecal metabolites produced prior to consuming the wheat bran (control) and at 24 h after consuming both the high (120 g) and low (40 g) doses of wheat bran (Fig. 4) . The colonic metabolites have been analysed with each volunteer as their own control. This is necessary for work concerning the gut microbiota, as there is generally large inter-individual variation in the species present [21] . Of the metabolites quantitatively analysed, 16 were significantly modulated by the intervention. The metabolites significantly increased by consumption of the Data are given as mean ± standard deviation in ng cm high dose of wheat bran were ferulic acid, the hydrogenated product of the 5-5 linked ferulic acid dimer, the 8-5 linked ferulic acid dimer and 2-hydroxyphenylpropionic acid (Table  8 and 9 ). Enterolactone and 3,5-dihydroxybenzoic acid were significantly increased on the intervention with the low dose of wheat bran only. Again, high amounts of metabolites likely to be derived from metabolism of protein were present in the faecal samples collected throughout the intervention. Some of these (4-cresol, phenylacetic acid, 4-hydroxyphenylacetic acid, phenyllactic acid, 4-hydroxyphenyllactic acid, indole-3-acetic, indole-3-pyruvic and indole-3-lactic acid) were found to be substantially lower in the colon 24 h following consumption of the large dose of the wheat bran intervention product, although these decreases were not significant.
Discussion
Consumption of ready-to-eat wheat bran cereal resulted in significant absorption of phytophenols early in the gastrointestinal tract and urinary excretion within 5 h of consuming the intervention product. Many of the phytophenols identified (vanillic acid, 4-hydroxy-3-methoxyacetophenone, ferulic acid and sinapic acid) were previously shown to have anti-inflammatory activity [22] to inhibit peroxidase and lipoxygenase enzymes (salicylic acid, 4-hydroxybenzoic acid, protocatechuic acid, 2,5-and 3,5-dihydroxybenzoic acids) [23, 24] and to be redox active [25] . The metabolites that were found to be significantly increased in the colon (as measured by their presence in faecal samples) 24 h following the intervention were ferulic acid, the hydrogenated product of the 5-5 linked dimer and the 8-5 linked ferulic dimer. Wheat bran is particularly rich in the 5-5-linked dimer of ferulic acid and the hydrogenated product of this dimer is the major form produced by the gut bacteria at physiological concentrations [26] . Monomeric and dimeric ferulic acid and the major gut metabolites of these compounds are potent anti-inflammatory compounds, at low concentrations, which are easily achievable in vivo [22, 26] . Bioavailability of certain classes of phytophenols has been extensively reviewed [27] . Several studies have reported the availability of free ferulic acid early in the GI tract, but there are fewer studies reporting the availability of ferulic acid bound to other cell wall components such as arabinoxylans [28] [29] [30] . Increased bioavailability of ferulic acid and its metabolites was observed following consumption of processed whole wheat bread; this was associated with significantly lower anti-inflammatory cytokines in LPS-stimulated blood following consumption [31] . There have been very few human studies reporting the bioavailability of the ferulic dimers, which are major components of wheat bran in either the gut or systemic circulation. Coffeederived ferulic acid dimers were shown to be bioavailable in both plasma and urine [32] . Interestingly, a trend toward lower plasma plasminogen activator inhibitor 1 with higher excretion of ferulic acid and dehydrodiferulic acid was also reported [33] . Of the many factors considered to contribute to the development of diseases such as cardiovascular disease, coronary artery disease and type 2 diabetes mellitus, there is substantial evidence for the chronic low-grade stimulation of inflammatory mediators [34] . Diets rich in fibre such as wheat bran have potential to deliver anti-inflammatory compounds directly to the gut and through hepatic circulation in a sustained manner to the vascular system, as well as delivering an acute postprandial dose. Indeed, WG wheat consumption reduced inflammation in a randomised controlled trial on overweight and obese individuals, with concomitant increases in ferulic acid and metabolites [35] . Inflammatory status and lipid profiles were also improved by ferulic acid supplementation in hypercholesterolemic subjects [36] . In summary, these data demonstrates that several phytochemicals and their metabolites present in wheat bran were found to be significantly increased in urine, plasma and FWs samples obtained from volunteers after consuming wheat bran based ready-to-eat cereal. Many of the metabolites and, in particular, ferulic acid and its derivatives are known to exhibit anti-inflammatory activity and impact on redox pathways [22] [23] [24] [25] . This may, in part, explain the beneficial effects of WG consumption on systemic, gut and general health. 
